Previous close | 12.11 |
Open | 12.38 |
Bid | 12.16 x 300 |
Ask | 12.23 x 300 |
Day's range | 11.91 - 12.58 |
52-week range | 10.93 - 28.35 |
Volume | |
Avg. volume | 925,214 |
Market cap | 777.996M |
Beta (5Y monthly) | 1.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Viridian Therapeutics ( NASDAQ:VRDN ) First Quarter 2024 Results Key Financial Results Net loss: US$48.5m (loss...
Discover key insights from VRDN's Q1 2024 earnings, including trial successes, financial stability, and future regulatory plans.
How VRDN's Financial Performance Measures Up Against Market Expectations